TY - JOUR
T1 - The Use of Premixed Drugs in Commodity Packets in the Population
T2 - Prevalence and Correlates Revealed by the 2018 National Survey of Substance Use in Taiwan
AU - Wu, Shang Chi
AU - Chen, Lian Yu
AU - Hsiao, Po Chang
AU - Ting, Te Tien
AU - Yen, Cheng Fang
AU - Chang, Shu Sen
AU - Li, Chung Yi
AU - Yang, Hao Jan
AU - Yen, Chia Feng
AU - Chen, Chuan Yu
AU - Huang, Jiun Hau
AU - Tu, Yu Kang
AU - Chen, Wei J.
N1 - Publisher Copyright:
© 2023 Shang-Chi Wu et al.
PY - 2024
Y1 - 2024
N2 - Background: Administering premixed drugs in commodity packets was first reported in Asia in 2015, but there continues to be a dearth of related population-based data. This study aimed at examining (1) the prevalence of drug-packet use in the population and (2) the sociodemographic profiles, particularly gender distribution, of drug-packet users. Methods: Data were derived from a survey of 18,626 Taiwanese civilians, aged 12–64 years, using stratified, multi-stage, random sampling in 2018. Participants anonymously completed a computer-assisted self-interview on tablet computers which covered the use and problematic use of illicit drugs/inhalants, prescription drugs, and other psychoactive substances. Results: Approximately 1.46% of respondents had a lifetime use of illicit drugs, with drugs in commodity packets (0.18%) being ranked the fifth-most commonly used illicit drugs, higher than nitrous oxide (0.14%) and heroin (0.09%). Ten formats of drug packets were endorsed by users. Approximately 81.6% of persons with drug packet use had lifetime use of other illicit drugs. The correlates of the use of drugs in commodity packets were different from those of the exclusive use of other drugs, particularly concerning the lack of gender differences in the former category in the whole sample and the subgroups of various socio-demographic characteristics and other substance use. Conclusion: Drugs in commodity packets have become a common way of administering illicit drugs in the population in Taiwan, and there were no gender differences among users. Our findings have implications for more efficient drug testing and culturally appropriate intervention for drug-packet use.
AB - Background: Administering premixed drugs in commodity packets was first reported in Asia in 2015, but there continues to be a dearth of related population-based data. This study aimed at examining (1) the prevalence of drug-packet use in the population and (2) the sociodemographic profiles, particularly gender distribution, of drug-packet users. Methods: Data were derived from a survey of 18,626 Taiwanese civilians, aged 12–64 years, using stratified, multi-stage, random sampling in 2018. Participants anonymously completed a computer-assisted self-interview on tablet computers which covered the use and problematic use of illicit drugs/inhalants, prescription drugs, and other psychoactive substances. Results: Approximately 1.46% of respondents had a lifetime use of illicit drugs, with drugs in commodity packets (0.18%) being ranked the fifth-most commonly used illicit drugs, higher than nitrous oxide (0.14%) and heroin (0.09%). Ten formats of drug packets were endorsed by users. Approximately 81.6% of persons with drug packet use had lifetime use of other illicit drugs. The correlates of the use of drugs in commodity packets were different from those of the exclusive use of other drugs, particularly concerning the lack of gender differences in the former category in the whole sample and the subgroups of various socio-demographic characteristics and other substance use. Conclusion: Drugs in commodity packets have become a common way of administering illicit drugs in the population in Taiwan, and there were no gender differences among users. Our findings have implications for more efficient drug testing and culturally appropriate intervention for drug-packet use.
UR - http://www.scopus.com/inward/record.url?scp=85192424125&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85192424125&partnerID=8YFLogxK
U2 - 10.2188/jea.JE20220356
DO - 10.2188/jea.JE20220356
M3 - Article
C2 - 37460297
AN - SCOPUS:85192424125
SN - 0917-5040
VL - 34
SP - 218
EP - 227
JO - Journal of epidemiology
JF - Journal of epidemiology
IS - 5
ER -